3-D Matrix, Ltd. (TYO:7777)

Market Cap	64.73B +365.8%
Revenue (ttm)	9.22B +38.4%
Net Income	1.25B
EPS	9.63
Shares Out	124.96M
PE Ratio	53.77
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,925,000
Average Volume	5,279,220
Open	530.00
Previous Close	530.00
Day's Range	501.00 - 533.00
52-Week Range	117.00 - 793.00
Beta	0.86
RSI	49.91
Earnings Date	Jun 12, 2026

About 3-D Matrix

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 114
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7777

Financial Performance

In fiscal year 2025, 3-D Matrix's revenue was 6.93 billion, an increase of 51.13% compared to the previous year's 4.59 billion. Losses were -2.50 billion, 880.8% more than in 2024.